Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylated circulating tumor DNA in blood: power in cancer prognosis and response
Authors
Keywords
-
Journal
ENDOCRINE-RELATED CANCER
Volume 23, Issue 3, Pages R157-R171
Publisher
Bioscientifica
Online
2016-01-14
DOI
10.1530/erc-15-0369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Digital PCR quantification ofMGMTmethylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
- (2015) L. Barault et al. ANNALS OF ONCOLOGY
- Sox17 Promoter Methylation in Plasma DNA Is Associated With Poor Survival and Can Be Used as a Prognostic Factor in Breast Cancer
- (2015) Deyuan Fu et al. MEDICINE
- Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients
- (2015) I. Balgkouranidou et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence
- (2015) Aaron M. Horning et al. PROSTATE
- Methylome sequencing in triple-negative breast cancer reveals distinct methylation clusters with prognostic value
- (2015) Clare Stirzaker et al. Nature Communications
- RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
- (2015) Yujin Kim et al. Clinical Epigenetics
- Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer
- (2015) Hong Wang et al. Clinical Epigenetics
- Quantification of Cell-Free mSHOX2 Plasma DNA for Therapy Monitoring in Advanced Stage Non-Small Cell (NSCLC) and Small-Cell Lung Cancer (SCLC) Patients
- (2015) Bernd Schmidt et al. PLoS One
- Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma
- (2015) Li Ming Zhu et al. Oncotarget
- Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
- (2014) M. Ignatiadis et al. ANNALS OF ONCOLOGY
- MethylatedTIMP-3DNA in Body Fluids Is an Independent Prognostic Factor for Gastric Cancer
- (2014) Jiang-Liu Yu et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- ESR1gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients
- (2014) Joaquina Martínez-Galán et al. BMC CANCER
- Methylation-capture and Next-Generation Sequencing of free circulating DNA from human plasma
- (2014) Kristina Warton et al. BMC GENOMICS
- Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer
- (2014) K L Mahon et al. BRITISH JOURNAL OF CANCER
- Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
- (2014) I Balgkouranidou et al. BRITISH JOURNAL OF CANCER
- Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer
- (2014) Mary Jo Fackler et al. CANCER RESEARCH
- Circulating Methylated MINT2 Promoter DNA Is a Potential Poor Prognostic Factor in Gastric Cancer
- (2014) Jing Han et al. DIGESTIVE DISEASES AND SCIENCES
- Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma Patients
- (2014) I-Ying Kuo et al. International Journal of Medical Sciences
- XAF1 directs apoptotic switch of p53 signaling through activation of HIPK2 and ZNF313
- (2014) M.-G. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Methylation of tumor suppressor genes in a novel panel predicts clinical outcome in paraffin-embedded bladder tumors
- (2014) Rodrigo García-Baquero et al. TUMOR BIOLOGY
- RETRACTED ARTICLE: Promoter methylation of DAPK gene may contribute to the pathogenesis of nonsmall cell lung cancer: a meta-analysis
- (2014) Fan-Fan Li et al. TUMOR BIOLOGY
- DNA methylation markers for early detection of women’s cancer: promise and challenges
- (2014) Timo Wittenberger et al. Epigenomics
- Differential TIMP3 expression affects tumor progression and angiogenesis in melanomas through regulation of directionally persistent endothelial cell migration
- (2013) Asha M. Das et al. ANGIOGENESIS
- Circulating cell free DNA: Preanalytical considerations
- (2013) Safia El Messaoudi et al. CLINICA CHIMICA ACTA
- Assessment of SOX17 DNA methylation in cell free DNA from patients with operable gastric cancer. Association with prognostic variables and survival
- (2013) Ioanna Balgkouranidou et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
- (2013) Christa Haldrup et al. JOURNAL OF CLINICAL ONCOLOGY
- Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients
- (2013) Anastasia A. Ponomaryova et al. LUNG CANCER
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
- (2013) Sarah-Jane Dawson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
- (2013) Zhi-Qiang Ling et al. PLoS One
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- Clinical Significance of Promoter Hypermethylation of ERβ and RARβ2 in Tumor and Serum DNA in Indian Breast Cancer Patients
- (2012) Sameer Mirza et al. ANNALS OF SURGICAL ONCOLOGY
- Hypermethylated 14-3-3-σ and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis
- (2012) Mercedes Zurita et al. BMC CANCER
- CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients
- (2012) Dawn P. Bradly et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma
- (2012) Z.Q. Ling et al. EJSO
- Prognostic role of methylated free circulating DNA in colorectal cancer
- (2012) Alexander B. Philipp et al. INTERNATIONAL JOURNAL OF CANCER
- AIM1 and LINE-1 Epigenetic Aberrations in Tumor and Serum Relate to Melanoma Progression and Disease Outcome
- (2012) Sojun Hoshimoto et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Inhibition of SOX17 by MicroRNA 141 and Methylation Activates the WNT Signaling Pathway in Esophageal Cancer
- (2012) Yan Jia et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- DNA methylation profiling in the clinic: applications and challenges
- (2012) Holger Heyn et al. NATURE REVIEWS GENETICS
- Epigenetics and the environment: emerging patterns and implications
- (2012) Robert Feil et al. NATURE REVIEWS GENETICS
- Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients
- (2012) Noriko Fujita et al. ONCOLOGY
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- DNA methylation of circulating DNA: a marker for monitoring efficacy of neoadjuvant chemotherapy in breast cancer patients
- (2012) Gayatri Sharma et al. TUMOR BIOLOGY
- Personalization of prostate cancer prevention and therapy: are clinically qualified biomarkers in the horizon?
- (2012) Timothy A Yap et al. EPMA Journal
- Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients
- (2011) Georg Göbel et al. BREAST CANCER RESEARCH AND TREATMENT
- Knockdown of RARB2 identifies a dual role in cancer
- (2011) Jane J. Pappas et al. GENES CHROMOSOMES & CANCER
- Prognostic and diagnostic significance of DNA methylation patterns in high grade serous ovarian cancer
- (2011) Céline Montavon et al. GYNECOLOGIC ONCOLOGY
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification
- (2011) Bing Zou et al. MOLECULAR CARCINOGENESIS
- Cancer epigenetics reaches mainstream oncology
- (2011) Manuel Rodríguez-Paredes et al. NATURE MEDICINE
- Tumor suppressor XIAP-Associated factor 1 (XAF1) cooperates with tumor necrosis factor-related apoptosis-inducing ligand to suppress colon cancer growth and trigger tumor regression
- (2010) Shui Ping Tu et al. CANCER
- Methylation patterns in cell-free plasma DNA reflect removal of the primary tumor and drug treatment of breast cancer patients
- (2010) Thomas E. Liggett et al. INTERNATIONAL JOURNAL OF CANCER
- Association of circulating tumor cells with tumor-related methylated DNA in patients with hormone-refractory prostate cancer
- (2010) Takatsugu Okegawa et al. INTERNATIONAL JOURNAL OF UROLOGY
- Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer
- (2010) Mónica Castro et al. Journal of Translational Medicine
- Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients
- (2010) Gayatri Sharma et al. LIFE SCIENCES
- First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients
- (2010) Fernanda Salazar et al. LUNG CANCER
- Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a
- (2010) Wen-bin Liu et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma
- (2010) Imen Miladi-Abdennadher et al. TUMOR BIOLOGY
- Qualitative analysis of Adenomatous Polyposis Coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker
- (2009) Maryam Zare et al. BMC CANCER
- RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
- (2009) A Misawa et al. BRITISH JOURNAL OF CANCER
- Clinical significance of Stratifin, ERα and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients
- (2009) Sameer Mirza et al. CLINICAL BIOCHEMISTRY
- Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome
- (2009) Andreas-Claudius Hoffmann et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- DNA hypermethylation and clinicopathological features in breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study
- (2008) Meng Hua Tao et al. BREAST CANCER RESEARCH AND TREATMENT
- Epigenetic Inactivation of the Canonical Wnt Antagonist SRY-Box Containing Gene 17 in Colorectal Cancer
- (2008) W. Zhang et al. CANCER RESEARCH
- Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma
- (2008) S. Yagyu et al. CLINICAL CANCER RESEARCH
- Circulating mutant DNA to assess tumor dynamics
- (2008) Frank Diehl et al. NATURE MEDICINE
- Persistent epigenetic differences associated with prenatal exposure to famine in humans
- (2008) B. T. Heijmans et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer
- (2007) Jörg Ellinger et al. JOURNAL OF UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started